The Institute of State and Regional Affairs at Penn State Harrisburg has released a report to help guide strategic planning in response to the COVID-19 outbreak in Pennsylvania. The report compares counties in Pennsylvania based on medical risk factors relating to COVID-19.
The Penn State Center for Security Research and Education, in collaboration with Penn State Harrisburg, Penn State Homeland Security Programs, and the Pennsylvania Emergency Management Agency, held a tabletop exercise that addressed first-responder and whole-community response and resilience to the ongoing opioid crisis.
Through a five-year, $1.9 million grant funded by the National Institute of Diabetes and Digestive and Kidney Diseases within the National Institutes of Health, researchers are studying the protein REDD1, which may play a role in how the body responds to hormones like insulin or cortisol. Understanding that role could lead to advances in the treatment of obesity, diabetes and other insulin resistant conditions.
Williamson said that his REDD1 research began serendipitously. “Much like anything, the question I was pursuing then opened up even more questions. While working on other related research, I began chipping away at this REDD1 finding year by year."
Researchers led by David Williamson are trying to understand the role that the protein REDD1 may play in how the body responds to hormones like insulin or cortisol, which could lead to advances in the treatment of obesity, diabetes, and other insulin resistant conditions.
Gina Brelsford was like any other new professor – she hoped she wouldn’t embarrass herself in front of her students. As a new instructor in clinical psychology at Penn State Harrisburg and a soon-to-be mother, she was nervous for many reasons.